Patents/Assignees

Immatics Biotechnologies GmbH

177 patents in portfolio

US12103984utility2024
Peptides, Combination of Peptides, and Cell Based Medicaments for Use in Immunotherapy Against Urinary Bladder Cancer and Other Cancers
0 cites
US12097249utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Prostate Cancer and Other Cancers
0 cites
US12097248utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Hepatocellular Carcinoma (HCC) and Other Cancers
0 cites
US12084486utility2024
Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
0 cites
US12084522utility2024
Peptides, Combination of Peptides, and Cell Based Medicaments for Use in Immunotherapy Against Urinary Bladder Cancer and Other Cancers
0 cites
US12076379utility2024
A*03 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
0 cites
US12076380utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Hepatocellular Carcinoma (HCC) and Other Cancers
0 cites
US12076381utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Prostate Cancer and Other Cancers
0 cites
US12070491utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Hepatocellular Carcinoma (HCC) and Other Cancers
0 cites
US12071458utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Ovarian Cancer and Other Cancers
0 cites
US12064465utility2024
Immunotherapy Against Several Tumors Including Gastrointestinal and Gastric Cancer
0 cites
US12065471utility2024
B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
0 cites
US12065477utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Ovarian Cancer and Other Cancers
0 cites
US12059458utility2024
Peptides and Combination of Peptides and Scaffolds for Use in Immunotherapy Against Renal Cell Carcinoma (RCC) and Other Cancers
0 cites
US12060399utility2024
Immunotherapy with A*01 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
0 cites
US12060400utility2024
Peptides for Use in Immunotherapy Against Cancers
0 cites
US12060406utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Tumors
0 cites
US12036271utility2024
Peptides and Combination of Peptides as Targets or Active Ingredients for Use in Immunotherapy Against AML and Other Cancers
0 cites
US12029785utility2024
GINS2 Peptide and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
0 cites
US12023372utility2024
Peptides and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
0 cites

← PreviousPage 4 of 9Next →